Heron Therapeutics | HRTX - Operating Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Heron Therapeutics

Heron Therapeutics reported $-33063000 in Operating Profit for its fiscal quarter ending in March of 2023.


Operating Profit Change
ALKERMES ALKS:US USD -47494000 26.91M
Alnylam Pharmaceuticals ALNY:US USD -149807000 38.81M
ANI Pharmaceuticals ANIP:US USD 9.9M 8.07M
Anika Therapeutics ANIK:US USD 2.53M 9.2M
Arrowhead Research ARWR:US USD 48.16M 90.3M
Eisai 4523:JP JPY 26.22B 17.65B
Emergent BioSolutions EBS:US USD -148100000 83M
Endo International ENDP:US USD 3.46M 240.32M
Esperion Therapeutics ESPR:US USD -48605000 6.09M
GlaxoSmithKline GSK:LN GBP 2.08B 215M
Heron Therapeutics HRTX:US USD -33063000 12.71M
Immunogen IMGN:US USD -42393000 17.17M
Insmed INSM:US USD -148158000 3.32M
Ligand Pharmaceuticals LGND:US USD 14.2M 2.03M
Merck & Co MRK:US USD 3.72B 286M
Nektar Therapeutics NKTR:US USD -134710000 82.24M
Neurocrine Biosciences NBIX:US USD -114200000 217.6M
Pacira PCRX:US USD -20017000 10.12M
Regeneron Pharmaceuticals REGN:US USD 946.7M 200.1M
Roche Holding ROG:VX 5.93B 5.62B
Sangamo BioSciences SGMO:US USD 18.03M 73.43M
Surmodics SRDX:US USD -6583000 646K
Ultragenyx Pharmaceutical RARE:US USD -154105000 8.48M
Veracyte VCYT:US USD -10498000 5.08M
Vertex Pharmaceuticals VRTX:US USD 779M 254.5M